Home
Home
Brain Tumor Education
Brain Tumor Education
About GammaTile
About GammaTile
Clinical Trials
Clinical Trials
- Clinical Trials
- Clinical Trials FAQ
Contact
Contact
Resource Center
Resource Center

FIND A GAMMATILE CENTER

Home
Home
Brain Tumor Education
Brain Tumor Education
About GammaTile
About GammaTile
Clinical Trials
Clinical Trials
- Clinical Trials
- Clinical Trials FAQ
Contact
Contact
|
Resource Center
Resource Center
FIND A GAMMATILE CENTER

Contact us

Use the contact form below for more information about GammaTile^® radiation treatment for brain tumors or to connect with our team.

Visit our GammaTile Center Locator
to find a GammaTile provider near you.

MKT-438-01

IMPORTANT SAFETY INFORMATION

GammaTile^® is indicated as a treatment for patients with newly diagnosed malignant intracranial neoplasms and patients with recurrent intracranial neoplasms. The potential for, and symptoms of, adverse events related to radiation exposure vary depending on the radiosensitivity of the exposed tissue, the amount of radiation delivered, and the placement of GammaTile(s). Serious side effects related to GammaTile Therapy are rare, and may include radiation brain changes including necrosis. GammaTile Therapy should not be used for patients with a known history of hypersensitivity to bovine-derived materials. Possible complications can occur with any neurosurgical procedure, including cerebrospinal fluid leaks, infection, delayed hemorrhage, and adhesion formation.

Instructions for Use - GammaTile Device
Instructions for Use - Radiation Shielding Tray
Terms of Use
Privacy Policy
About GT Medical Technologies

© 2026 GT Medical Technologies, Inc. All rights reserved.
GammaTile^® is a registered trademark of GT Medical Technologies, Inc.

GT Medical Technologies is committed to improving the lives of patients with brain tumors through innovative solutions that elevate the standard of care. Learn More.